Hospital Acquired Infections, or HAIs, inflict immense suffering upon patients, and they are a leading cause of death. Over the last decade, there has been an alarming increase in the number of antibiotic resistant infections that can no longer be cured, and reports of superbug related deaths have become common.
The patient environment is an ideal breeding ground for a superbug. This is because pathogens can thrive on all kinds of contaminated surfaces. The cross contamination of a surface that is frequently touched during the delivery of care can increase the risk of exposing a patient to a superbug. A life threatening HAI may develop following this kind of superbug exposure.
HAIs can be spread by preventable failures in the practice of hospital infection control. Contaminated surfaces require rigorous disinfection. However, in busy healthcare environments, a surface can be recolonized soon after sanitization.
There are clear practical limits to the frequency with which contaminated surfaces can be disinfected and, because pathogenic load can quickly rebound, germs have traditionally been one step ahead of HCPs in the fight against HAIs. However, the increasing incidence of antibiotic resistant HAIs has transformed a once commonly accepted need to improve hospital infection control into an urgent global health priority .
Hygenica’s mission is to prevent the spread of superbugs for the benefit of patients, by ensuring that healthcare facilities appropriately adopt its best-in-class antimicrobial Fantex technology.
The NHS spends £1 billion each year on treating HAIs.
100,000 patients contract an infection during hospital stay each year.
9,000 deaths occur annually due to nosocomial infections. Many of these deaths may be preventable by improving standards of hygiene